Orlando Rocco, Pelizzo Maria Rosa, Lirussi Flavio
Department of Medical and Surgical Sciences, University of Padova, Via Giustiniani, 2, 35128 Padua, Italy.
Anticancer Res. 2003 May-Jun;23(3C):2929-31.
Adrenocortical carcinoma is a rare but aggressive malignancy with metastases being present in 30-40% of cases at the time of diagnosis. A number of prognostic factors have been identified in patients with adrenocortical carcinoma, but criteria predicting survival are not uniform. We report the case of a 58-year-old man with a large, non-functioning and poorly-differentiated adrenocortical carcinoma who, according to current knowledge, was expected to have a short survival. On the contrary, the prompt diagnosis and curative resection of the primary tumour, together with two reoperations for local recurrences, allowed a 15-year survival and a good quality of life. A revision of both clinical and histological prognostic factors is therefore needed in patients with this type of malignancy.
肾上腺皮质癌是一种罕见但侵袭性强的恶性肿瘤,30% - 40%的病例在诊断时已有转移。在肾上腺皮质癌患者中已确定了许多预后因素,但预测生存的标准并不统一。我们报告了一例58岁男性患者,患有巨大、无功能且低分化的肾上腺皮质癌,根据目前的认知,预计其生存期较短。相反,对原发肿瘤的及时诊断和根治性切除,以及针对局部复发的两次再次手术,使其存活了15年且生活质量良好。因此,对于这类恶性肿瘤患者,需要对临床和组织学预后因素进行重新审视。